CASI Pharmaceuticals, Inc. announced on December 2, 2021, the Compensation Committee of the Board of Directors of recommended, and, on December 8, 2021, the Board approved, a title change for Alexander A. Zukiwski, MD, from Chief Medical Officer to Executive Vice President and Chief Medical Officer. In addition, the Board expanded certain of Dr. Zukiwski’s responsibilities. In connection with these changes, Dr. Zukiwski’s base salary was raised to USD 504,000. Dr. Zukiwski was also allowed a USD 1,500 per month car allowance. Both are retroactive to August 16, 2021. In addition, the Board approved and amendment to Dr. Zukiwski’s change in control agreement te extend the severance payments from nine months to 12 months.